Wednesday, October 14, 2026
ExploreSearch
Finance Via News
Via News Knowledge File

Meta Platforms

organization80% conf.·synced Oct 14, 2026

Social media company implementing Dolby Vision on Instagram and Facebook, and Dolby Atmos/Vision on Oculus

60
sourced metrics
982
relationships
20
stated objectives
6
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Price 52 Week High
777.59USD
Oct 13, 2026reference only
Stock Return Ytd
17.2%
Oct 13, 2026reference only
Price 52 Week Low
525.72USD
Oct 13, 2026reference only
Stock Price
762.50USD
Oct 13, 2026reference only
Net Income
15848000000.0USD
Jun 30, 2026reference only
Eps
6.18USD_per_share
Jun 30, 2026reference only
Rd Expense
21656000000.0USD
Jun 30, 2026reference only
Operating Income
18775000000.0USD
Jun 30, 2026reference only
Revenue
60801000000.0USD
Jun 30, 2026reference only
Total Assets
449956000000.0USD
Jun 30, 2026reference only
Cost Of Revenue
11330000000.0USD
Jun 30, 2026reference only
Total Liabilities
188735000000.0USD
Jun 30, 2026reference only
Cash
15462000000.0USD
Jun 30, 2026reference only
Stockholders Equity
261221000000.0USD
Jun 30, 2026reference only
Operating Cash Flow
32226000000.0USD
Mar 31, 2026reference only
Capex
18997000000.0USD
Mar 31, 2026reference only

Stated objectives

Double-digit ad revenue growth without further margin erosion

source
target: 20% by 2026-01-01 00:00:00stated

Hold operating margins in the high 30s while growing revenue

source
target: high 30s percent by 2026-01-01 00:00:00stated

Metaverse budget cuts

source
target: 30% stated

Build a 1-gigawatt data center in Indiana as part of AI infrastructure buildout

source
target: 1 gigawatt capacity stated

Meta Platforms targets Q1 2026 total revenues in the range of $53.5-$56.5 billion

source
target: $53.5-$56.5 billion stated

Meta plans to complete rollout of ads in WhatsApp Status globally throughout 2026

source
stated

Meta investing $115-$135 billion in 2026 capital spending on AI research, models, and infrastructure

source
target: $115-$135 billion capex stated

Meta intends to bring ads to newer platforms and integrate AI across all layers of marketing and customer engagement funnel

source
stated

Meta committed to significant AI infrastructure capital expenditure

source
target: Part of collective $650 billion commitment with Amazon, Goog stated

Expand AI agents capabilities through acquisition of Manus AI startup

source
target: 2 billion USD acquisition stated

Relationship graph · 982 connections

Competes with
174
Supplies to
140
Invested in
86
Developed by
85
Owns
81
Customer of
78
subsidiary of
76
Covered by
61
contracted by
Nebius Group N.V.

Via News coverage

Micron Is Spending Twice What It Did Two Years Ago on the AI Buildout, and Analysts Are Already Splitting on Who Gets Paid
October 9, 2026
Agentic AI Reaches Enterprise Software: Meta Hires a MongoDB CEO, Seed Rounds Fund Niche Agents, and One Investor Warns That AI Can't Do Maths
October 5, 2026
Micron's Capex Nearly Doubled to $15.9B and Its Cash Hit $25B: The AI Buildout in Verified Numbers, While Quantum and Consumer Stocks Lag
October 1, 2026
Capital Power Reaches Final Investment Decision on Meta-Linked Greenlight Gas Plant in Alberta
July 11, 2026
AMD Raises AI Chip Revenue Forecast to Double-Digit Billions, Launches MI350 Series
March 7, 2026
AI Rewires Wealth Management: Fintech Upstarts Challenge Wall Street With Tax Planning Tools
February 18, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com